Texas InstrumentsTPS76925DBVTLinear Regulators

LDO Regulator Pos 2.5V 0.1A 5-Pin SOT-23 T/R

Having trouble maintaining a steady voltage? This LDO TPS76925DBVT linear regulator from Texas Instruments will give you control over the voltage levels of your circuit. It has an overall accuracy of ±3 %. This device has a maximum power dissipation of 555 mW. Its typical dropout voltage at current is 0.071@100mA V. This voltage regulation device's single output can produce a current up to 0.1 A. The best way to provide power to your application is by using this, which needs a voltage of at least 2.7 V and no higher than 10 V. With a fixed output that has a voltage of 2.5 V, this is power management at its best. At a load regulation of 12mV(Typ) and line regulation of 0.04%/V(Typ) your circuit is capable of maintaining a constant voltage level at your output. Its maximum power dissipation is 555 mW. Tape and reel packaging will encase this product during shipment, in order to ensure safe delivery and enable quick mounting of components. Its polarity is positive. This voltage regulation device has an operating temperature range of -40 °C to 125 °C.

Import TariffMay apply to this part

15 parts: Ships in 2 days

This item has been discontinued

    Total$0.50Price for 1

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2212+
      Manufacturer Lead Time:
      99 weeks
      Minimum Of :
      1
      Maximum Of:
      15
      Country Of origin:
      China
         
      • Price: $0.4995
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2212+
      Manufacturer Lead Time:
      99 weeks
      Country Of origin:
      China
      • In Stock: 15 parts
      • Price: $0.4995

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.